Anzeige
Mehr »
Dienstag, 10.02.2026 - Börsentäglich über 12.000 News
Durchbruch. Durchbruch. Durchbruch. Kutcho Copper hat DAS Signal gesendet
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
568 Leser
Artikel bewerten:
(1)

priMED Medical Products Appoints Lucas Ethier as Executive Vice President

priMED Medical Products Appoints Lucas Ethier as Executive Vice President

Company fortifies its commitment to market growth, product focus and worldwide expansion

EDMONTON, AB / ACCESSWIRE / July 29, 2019 / priMED Medical Products Inc. (priMED), a global medical product manufacturer, announced today Lucas Ethier has been promoted to Executive Vice President.

With 18 years of experience at priMED, including 10 years of leadership experience in business development and product strategy, Ethier's depth of industry and product knowledge and proven ability to build high-performance teams is key to growing priMED's global business and private label customer base.

"Lucas has driven us to become one of the leading protective apparel manufacturers in the global healthcare market."

"With his market and product expertise, industry connections, sales acumen, and ability to build strategic partnerships, Lucas has driven us to become one of the leading protective apparel manufacturers in the global healthcare market," says David Welsh, priMED's President and CEO. "We have had a busy year evolving our leadership team, and promoting Lucas to the role of EVP is another step in rounding out our world class team. We will continue to look to Lucas' leadership and experience as we focus on global growth in priMED's medical protective apparel business."

After starting with priMED in 2002 as an Operations Analyst, Ethier has grown up through the ranks in Operations, Supply Chain, Sales and Marketing, and was instrumental in priMED's revenue growth over the last decade. Most recently, Ethier served as the VP, Marketing, which saw significant product expansion and revenue growth under his leadership. With the promotion of Ethier to EVP, priMED fortifies its commitment to market growth, product focus and worldwide expansion.

"With the growing momentum in all of our protective apparel categories, there is a tremendous opportunity for priMED to continue to bring value to global healthcare."

"priMED has a rich history of innovation, industry-leading products and highly engaged employees. With the growing momentum in all of our protective apparel categories, there is a tremendous opportunity for priMED to continue to bring value to global healthcare," says Ethier. "I'm excited to help lead this amazing company and deliver market strategies that reinforce priMED's market leading position while bringing new fans to the brand."

For more information:

Media Contact:

Craig Blackburn, Senior Manager, Brand and Engagement
Craig.Blackburn[at]priMED.ca

priMED Medical Products
#200, 2003-91 Street SW
Edmonton, Alberta T6X 0W8
Phone: 780 497 7600
Web: https://priMED.ca

About priMED Medical Products

priMED Medical Products Inc. is a dynamic, global medical product manufacturer specializing in high-quality personal protective apparel. On a mission to protect people from harmful substances and infectious disease, priMED is a leading Canadian provider to hospitals, clinics, labs and long-term care facilities, and offers branded, co-branded and private label products and services to its customers and international partners.

SOURCE: priMED Medical Products Inc.



View source version on accesswire.com:
https://www.accesswire.com/553875/priMED-Medical-Products-Appoints-Lucas-Ethier-as-Executive-Vice-President

© 2019 ACCESS Newswire
Vorsicht, geheim!
2026 startet mit einem Paukenschlag: Der DAX outperformt den US-Markt, Nachzügler holen auf. Ein erstes Signal, dass der Bullenmarkt an Breite gewinnt. Während viele Anleger weiter auf die großen Tech-Namen setzen, hat sich im Hintergrund längst ein Umschwung vollzogen. Der Fokus verschiebt sich weg von überteuerten KI-Highflyern hin zu soliden Qualitätswerten aus der zweiten Reihe.

Anleger, die jetzt clever agieren, setzen nicht auf das, was war, sondern auf das, was kommt. Unternehmen mit gesunder Bilanz, unterschätztem Potenzial und begrenztem Abwärtsrisiko könnten 2026 zu den großen Gewinnern zählen. Die Gefahr einer schärferen Korrektur bleibt real, gerade für passiv aufgestellte Investoren.

In unserem neuen Spezialreport stellen wir fünf Aktien vor, die genau jetzt das Potenzial für überdurchschnittliche Renditen bieten. Stark, günstig und bislang kaum im Fokus.

Jetzt kostenlosen Report herunterladen – bevor es andere tun!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.